66 results
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
8 Aug 23
Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer
10:30am
10-K
2022 FY
EX-10.13
PCSA
Processa Pharmaceuticals Inc
Annual report
30 Mar 23
12:00am
8-K
EX-10.1
PCSA
Processa Pharmaceuticals Inc
13 Feb 23
Processa Pharmaceuticals, Inc. Announces $6.25 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
4:05pm
8-K
EX-10.2
lcv5976vdjo3jv
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
uol5srldul9ul1q3xny5
24 Mar 22
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
0ou8 4zf70zm
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
EX-10.3
vs11v3
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.1
7236xzl4xumt kr
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.2
oywoh rd5k83c
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-10.1
2qslmj
13 Oct 20
Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
9:30am